167 related articles for article (PubMed ID: 31357859)
1. Diversity-Oriented Synthesis of Imidazo-Dipyridines with Anticancer Activity via the Groebke-Blackburn-Bienaymé and TBAB-Mediated Cascade Reaction in One Pot.
Li Y; Huang JH; Wang JL; Song GT; Tang DY; Yao F; Lin HK; Yan W; Li HY; Xu ZG; Chen ZZ
J Org Chem; 2019 Oct; 84(19):12632-12638. PubMed ID: 31357859
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor compounds identification from gossypol Groebke imidazopyridine product.
Wang W; Lu Y; Chen E; Shen K; Li J
Bioorg Chem; 2021 Sep; 114():105146. PubMed ID: 34328859
[TBL] [Abstract][Full Text] [Related]
3. Groebke-Blackburn-Bienaymé multicomponent reaction: emerging chemistry for drug discovery.
Shaaban S; Abdel-Wahab BF
Mol Divers; 2016 Feb; 20(1):233-54. PubMed ID: 26016721
[TBL] [Abstract][Full Text] [Related]
4. Diversity-Oriented Synthesis of [2.2]Paracyclophane-derived Fused Imidazo[1,2-a]heterocycles by Groebke-Blackburn-Bienaymé Reaction: Accessing Cyclophanyl Imidazole Ligands Library.
Stahlberger M; Schwarz N; Zippel C; Hohmann J; Nieger M; Hassan Z; Bräse S
Chemistry; 2022 Jan; 28(3):e202103511. PubMed ID: 34792822
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.
Sajith AM; Abdul Khader KK; Joshi N; Reddy MN; Syed Ali Padusha M; Nagaswarupa HP; Nibin Joy M; Bodke YD; Karuvalam RP; Banerjee R; Muralidharan A; Rajendra P
Eur J Med Chem; 2015 Jan; 89():21-31. PubMed ID: 25462222
[TBL] [Abstract][Full Text] [Related]
6. Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1.
Su JC; Chang CH; Wu SH; Shiau CW
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1248-1255. PubMed ID: 30261753
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel imidazopyrimidin-3-amines as anticancer agents.
Mahdavi M; Dianat S; Khavari B; Moghimi S; Abdollahi M; Safavi M; Mouradzadegun A; Kabudanian Ardestani S; Sabourian R; Emami S; Akbarzadeh T; Shafiee A; Foroumadi A
Chem Biol Drug Des; 2017 May; 89(5):797-805. PubMed ID: 27860301
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of imidazo[1,2-a]pyridines in a sequential one-pot Groebke-Blackburn modification using 2-aminopyridines, aldehydes and amines.
Flesch D; Schubert-Zsilavecz M
Pharmazie; 2015 Aug; 70(8):507-10. PubMed ID: 26380518
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxic characterization, and SAR study of imidazo[1,2-b]pyrazole-7-carboxamides.
Demjén A; Alföldi R; Angyal A; Gyuris M; Hackler L; Szebeni GJ; Wölfling J; Puskás LG; Kanizsai I
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800062. PubMed ID: 29888449
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activities of Groebke-Blackburn-Bienaymé-derived imidazo[1,2-a]pyridin-3-amines.
Shukla NM; Salunke DB; Yoo E; Mutz CA; Balakrishna R; David SA
Bioorg Med Chem; 2012 Oct; 20(19):5850-63. PubMed ID: 22925449
[TBL] [Abstract][Full Text] [Related]
12. Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity.
Gallud A; Vaillant O; Maillard LT; Arama DP; Dubois J; Maynadier M; Lisowski V; Garcia M; Martinez J; Masurier N
Eur J Med Chem; 2014 Mar; 75():382-90. PubMed ID: 24561668
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds.
Romagnoli R; Baraldi PG; Prencipe F; Balzarini J; Liekens S; Estévez F
Eur J Med Chem; 2015 Aug; 101():205-17. PubMed ID: 26141911
[TBL] [Abstract][Full Text] [Related]
14. Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure-activity relationship study.
Meenakshisundaram S; Manickam M; Pillaiyar T
Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900011. PubMed ID: 31596021
[TBL] [Abstract][Full Text] [Related]
15. Palladium(II)-Stabilized Pyridine-2-Diazotates: Synthesis, Structural Characterization, and Cytotoxicity Studies.
Tskhovrebov AG; Vasileva AA; Goddard R; Riedel T; Dyson PJ; Mikhaylov VN; Serebryanskaya TV; Sorokoumov VN; Haukka M
Inorg Chem; 2018 Feb; 57(3):930-934. PubMed ID: 29356518
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-cancer activity of 1,4-disubstituted imidazo[4,5-c]quinolines.
Thigulla Y; Akula M; Trivedi P; Ghosh B; Jha M; Bhattacharya A
Org Biomol Chem; 2016 Jan; 14(3):876-83. PubMed ID: 26592542
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel aliphatic amido/sulfonamido-quaternary ammonium salts as antitumor agents.
Song D; Yang JS; Kim SJ; Kim BK; Park SK; Won M; Lee K; Kim HM; Choi KY; Lee K; Han G
Bioorg Med Chem; 2013 Feb; 21(3):788-94. PubMed ID: 23266181
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents.
An W; Wang W; Yu T; Zhang Y; Miao Z; Meng T; Shen J
Eur J Med Chem; 2016 Apr; 112():367-372. PubMed ID: 26927488
[TBL] [Abstract][Full Text] [Related]
19. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors.
Liu TC; Peng X; Ma YC; Ji YC; Chen DQ; Zheng MY; Zhao DM; Cheng MS; Geng MY; Shen JK; Ai J; Xiong B
Acta Pharmacol Sin; 2016 May; 37(5):698-707. PubMed ID: 27041462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
